03/30/2023

Cheng Chuancheng, a deputy of the Meng Chao Tumber Tumber Hospital, Shanghai University: Opening more innovative therapies for tumor patients

Professor Cheng Chijie Professor Cheng Chiji, a Shanghai University, received a visit to Xinhuanet. Xinhuanet issued Xinhuanet: Hello, Cheng Governor, please talk about the meaning of precise medical care from the perspective of clinical and patients? Cheng Chi Miao: There is a idiom called "the right medicine". In fact, we have said that the precision medical care is also doing this.

There is no two identical leaves in the world, and there is an individual difference in patients’ disease. We hope that by precision medical care, in clinical practice, we are based on personalized differences in each patient, and to properly select and accurately apply suitable diagnosis and treatment methods, to achieve medical damage minimization, medical cost-effective, and maximum patient benefit. change. In the field of cancer treatment, the importance of precision medical care is more obvious.

Take targeted medicine as an example, there is currently a targeted drug, from the overall efficacy of lung cancer, but in patients with lung cancer having a specific genetic mutation is good.

Xinhua Net: What are the efforts and exploration of Meng Chao Tumber Hospital affiliated to the Shanghai University? Cheng Chi: 2012, the 3rd "Rehabilitation · Life Xinzhi" Medical High-end Forum, "The Father of China ‘s Hepatobiliary Surgery" Wu Mengchao proposed: "Looking for the’ God Particles ‘of Medical Sciences’ is ‘Precision Medicine’.

In July 2016, Men Mengchao and his student’s professor were jointly promoted the anti-cancer "Bai Ze Plan", based on a number of precision medical technology, including "10 years, more than 60% The advanced tumor regression, allowing 60% of the people to afford; 30 years, let people live healthy to natural life ".

In 2013, Professor Qian Qi was a Shanghai Cell Treatment Group to construct a "super cell-proof system" to create a "three integration" strategic closed loop in the field of cell therapeutic fields. Level health support and medical services. Shanghai University of Meng Chao Tumor Hospital is affiliated to Shanghai Cell Treatment Group, which is a "three-in-one" strategic closed-loop cell medical landing link, carrying out major tasks of cell therapy clinical research and transformation. However, cell therapy is a emerging technology, and its clinical conversion is a rigorous, complex, long process, and there are still many challenges to overcome.

However, we always believe that the road block and long, the rules will arrive, the line is not available, the future is in the future, and it is expected to open up more innovative therapies for tumor disease patients.

Xinhuanet: What initiatives have been taken to patients with precision medical services? What are the means and advantages of hospitals in inspection inspections? Cheng Chi Miao: On the one hand, we have created a precise tumor breakfast center. In accordance with the "Tumor Level 3 Prevention" concept, pay attention to the prevention of diseases. In the past year, the hospital has entered the community, the clinic, and the science lectures, etc., as a routine work, advance the "three-early prevention" of the tumor early detection, early diagnosis, early treatment.

Hospitals for different crowds, DNA methylation, genetic mutation, etc. also carried out inspection of gastrointestinaloscopy, PET-CT, cancer risk assessment, anti-cancer medical examination and tracking follow-up, targeted tumor clinical prevention and Rehabilitation prevention, improve the survival and quality of life of patients.

The hospital has a total of nearly 7,000 tumor breakfast services for nearly 7,000 people.

On the other hand, the hospital relies on the group’s cell therapy technology and product advantages, and the "cell therapy +" clinical research is fully promoted. The medical treatment of cell therapy is introduced, and "surgical + cell therapy" "radiotherapy + cell therapy" "chemotherapy + cell treatment "Some special clinical research diagnosis and treatment teams.

Hospital relying on the Group’s cell health, cell and Baize Inspection, and actively promotes clinical research transformation.

The hospital also cooperated with domestic well-known CROs to actively apply for national clinical drug testing institutions (GCP) filings, and strive to become a major participation unit for domestic cell treatment industry standards.

In the third aspect, the hospital takes full use of cell therapy clinical research frontier technology, integrating hospital discipline, and organizes multidisciplinary joint diagnosis ("MDT").

The hospital has established a hepatobiliary tumor, gastrointestinal tumor, gynecological tumor, urinary tumor, lung tumor, blood tumor, etc., using long-range consultation methods, establishing well-known domestic and foreign expert libraries, and jointly participate in the hospital MDT work.

In addition, the hospital has configured high-precious medical equipment to escort the patient. At present, hospital has VitalBeam stereo straight line accelerator, discovery710pet-ct, ultra-quiet magnetic resonance, panoramic dynamic movie 320-row super-spiral CT, DSA, etc.

Professor Cheng Chijie Professor Cheng Chiji, a Shanghai University, received a visit to Xinhuanet. Xinhuanet issued Xinhuanet: What do you think is an important indicator for measuring the high and low level of medical and academic levels? What to enhance the comprehensive competitiveness of the hospital? Cheng Chuancai: I think that scientific research level, technical characteristics and talent team are important indicators that measures the high and low medical care and academic level of a modern hospital. In terms of improving the comprehensive competitiveness of the hospital, Meng Chao Tumber Hospital affiliated to Shanghai has made a lot of work. In terms of clinical, scientific research and talents, the hospital establishes deep cooperation with Shanghai University. At present, Liu Changmong, the scientific research president of our hospital, is hired as part-time professors of Shanghai University, and Qian Jun is appointed as the deputy dean of Shanghai University Medical College, Qi Qijun, Li Zhong, and Ye Zhenlong were employed as a master of Shanghai University.

In the recruitment and cultivation of subsequent talents, the hospital is gradually developing high-end talents in Shanghai University (ie schools in the school in editing or non-editing, subsidiary hospital work) to introduce innovation models, widely absorbed clinical and scientific research high-end talents at home and abroad. join in.

The depth cooperation of Shanghai University and Hospital will further strengthen the construction of hospital scientific research and talent. Now, Shanghai University, Meng Chao Tumber Hospital, has become the committee unit of the China Medical Biotechnology Association, and the hospital is fortunate as the director’s member of the Director, will promote my country’s share of medical theoretical research, technological innovation, cross-region collaboration For those who provide academic exchanges and communication for scholars at home and abroad, and will also introduce the top talents at home and abroad to come to the hospital.

In addition to actively sponsored academic bodies, the hospital also participated in the China Rehabilitation Medicine Society and other associations and organizations.

The "Notum" held by the hospital has gained international attention. The Nobel Prize in Invite the Nobel Prize in the domain winners to conduct scientific research cooperation and academic exchanges.

On December 24, 2020, at the hospital unveiling ceremony, 36 Nobel Prize winners from the world sent a blessing video.

The 36 Nobel Prize winners not only brought blessings, but also provided international top scientific guidelines, introducing various perspective information and advanced knowledge of various perspectives such as global medical trends, industrial processes, scientific and technological breakthroughs. In addition, the hospital also published a group of high-level medical papers.

In the hospital, the hospital issued nearly 10 research papers in the hospital, with the highest impact factor.